Glioma heterogeneity in vitro: the significance of growth factors and gangliosides
- 1 October 1992
- journal article
- review article
- Published by Wiley in Neuropathology and Applied Neurobiology
- Vol. 18 (5) , 434-442
- https://doi.org/10.1111/j.1365-2990.1992.tb00809.x
Abstract
Despite renewed attempts by the WHO at updating the system of classification for brain tumours, most of the dynamic biological processes which underlie both the morphological appearances which form the basis for such systems and the malignant potential of gliomas remain an enigma to the neuropathologist. One feature recognized in human gliomas is their phenotypic and genotypic heterogeneity. Such cellular heterogeneity seen in the histological section is retained in vitro, at least during early passage. It is proposed that this heterogeneity is important in the growth and maintenance of the tumour and may be related to the activity of growth factors and gangliosides. Such molecules may not only influence the histoarchitecture of glial neoplasms but may also determine malignant progression and invasive potential. Moreover, there may be an intimate relationship between growth factors and gangliosides constituting an intricate feedback mechanism upon which the biological progression of gliomas depends.Keywords
This publication has 26 references indexed in Scilit:
- Response of low-passage human malignant gliomas in vitro to stimulation and selective inhibition of growth factor-mediated pathwaysJournal of Neurosurgery, 1991
- Production of basic fibroblast growth factor in cultured rat brain microgliaNeuroscience Letters, 1991
- A2B5 Surface ganglioside binding distinguishes between two GFAP-positive clones from a human glioma-derived cell lineNeuroscience Letters, 1990
- Growth factors in cultured human glioma cells: Differential effects of FGF, EGF and PDGF☆Cancer Letters, 1988
- Analysis of cellular expression of gangliosides by gene transfection I: GD3 expression in -transfected and transformed 3Y1 correlates with anchorage-independent growth activityBiochemical and Biophysical Research Communications, 1988
- Binding of momoclonal antibody A2B5 to gangliosidesBiochemical and Biophysical Research Communications, 1983
- The monoclonal antibody A2B5 is specific to ganglioside GQ1cBrain Research, 1983
- Relationship between gangliosides and doubling times in cultured human brain and brain tumor cellsCancer Letters, 1980
- Gangliosides in human brain tumorsLife Sciences, 1970